Trump launched the TrumpRx drug-discount website after striking price-cut deals with Pfizer and AstraZeneca, using 100% tariff threats as leverage. Critics panned the site while the UK braced for higher medicine costs under the pressure campaign.
Sep 20, 2025 → Oct 11, 2025
The Trump administration has reached an agreement with pharmaceutical company AstraZeneca to lower drug prices. The deal was facilitated by the threat of tariffs, as confirmed by the president and top health officials. This agreement is…
Read original at NYT →14 updates from 4 sources over 3 weeks.
The Trump administration has reached an agreement with pharmaceutical company AstraZeneca to lower drug prices. The deal was facilitated by the threat of tariffs, as confirmed by the president and top health officials.…
Read original at NYT →The article discusses the emergence of TrumpRx, an AI-generated art project that has drawn criticism for its association with narcissism and fascism. The author argues that AI art has become the preferred aesthetic for…
Read original at Gizmodo →President Trump has announced a deal with AstraZeneca Plc to lower consumer prices on some of the company's drugs in exchange for tariff relief. This is the second major agreement between the White House and a…
Read original at Bloomberg →The UK government is considering raising the amount the National Health Service (NHS) pays pharmaceutical companies for medicines by up to 25%. This move is part of efforts to resolve a standoff with the industry and…
Read original at The Guardian →The Trump administration has announced a deal with Pfizer to potentially lower Medicaid drug prices, as well as the launch of a new website, TrumpRx, aimed at helping consumers purchase drugs directly from…
Read original at NYT →The Trump administration has announced a deal with Pfizer to lower the prices of some drugs. As part of this agreement, the administration will create a new website called TrumpRx, which will allow consumers to purchase…
Read original at NYT →Pfizer Inc. has reached an agreement with the Trump administration to avoid tariffs on the pharmaceutical industry. The deal involves Pfizer slashing the prices of some of its drugs by up to 85% and selling them…
Read original at Bloomberg →The Trump administration has announced plans to impose a 100% tariff on certain brand-name drugs imported from abroad. This move is intended to lower drug prices in the United States, a key issue for the president.…
Read original at NYT →The article discusses the proposed tariffs on pharmaceutical imports by the Trump administration. While the details of the tariffs were not entirely clear, it appears that many large pharmaceutical companies would be…
Read original at NYT →The Trump administration's proposed plan to impose a 100% tariff on branded and patented drug imports has been met with a tepid response from many investors. The plan includes exemptions for pharmaceutical companies…
Read original at Bloomberg →The article suggests that the Trump administration may attempt to force drug manufacturers to match lower European prices in the United States. A federal website notice, which was briefly removed and then reposted,…
Read original at NYT →President Donald Trump has announced a new round of tariffs, including a 100% duty on branded or patented pharmaceutical products starting October 1. This move is aimed at encouraging pharmaceutical companies to…
Read original at Bloomberg →Pharmacy middlemen, also known as pharmacy benefit managers (PBMs), are working on a voluntary proposal to modify their business practices. This comes as the Trump administration considers new regulations targeting the…
Read original at Bloomberg →The White House is reportedly considering the creation of a Trump-branded prescription drug website, dubbed "TrumpRx." The proposed platform would aim to provide Americans with access to lower-cost medications,…
Read original at Gizmodo →What this story stands on. Tier 0 is a primary record or the subject's own words; higher tiers must be attributed, never stated as bare fact.
The Trump administration has reached an agreement with pharmaceutical company AstraZeneca to lower drug prices. The deal was facilitated by the threat of tariffs, as confirmed by the president and top health officials. This agreement is…
View source →The article discusses the emergence of TrumpRx, an AI-generated art project that has drawn criticism for its association with narcissism and fascism. The author argues that AI art has become the preferred aesthetic for individuals engaged…
View source →President Trump has announced a deal with AstraZeneca Plc to lower consumer prices on some of the company's drugs in exchange for tariff relief. This is the second major agreement between the White House and a pharmaceutical company aimed…
View source →The UK government is considering raising the amount the National Health Service (NHS) pays pharmaceutical companies for medicines by up to 25%. This move is part of efforts to resolve a standoff with the industry and the Trump…
View source →The Trump administration has announced a deal with Pfizer to potentially lower Medicaid drug prices, as well as the launch of a new website, TrumpRx, aimed at helping consumers purchase drugs directly from manufacturers. The deal with…
View source →The Trump administration has announced a deal with Pfizer to lower the prices of some drugs. As part of this agreement, the administration will create a new website called TrumpRx, which will allow consumers to purchase drugs directly from…
View source →Tier key: T0 = Primary source · T1 = Wire · T2 = Outlet report · T3 = Commentary
Long-running fight over Trump-backed maps takes another turn as absentee voting is already under way in Missouri. This blog is now closed. Sign up for US Breaking News emails Xi…
This new task force is Trump's latest response to the debate over AI safety.
The Trump administration’s decision to revoke the visa of a Peruvian judge who sided with a Chinese company in a port dispute puts a new spotlight on the growing US-China rivalry…
As Bosnians vote in an election this weekend, the country is embracing the US president’s family and friends.
On Equity, we discussed the Trump administration's attempts to rebrand AI.
Donald Trump and Xi Jinping discuss Taiwan arms sales every time they get together but the American stance on the self-ruled island remains unchanged following the Chinese…
